Low-dose deoxycholic acid stimulates putrescine uptake in colon cancer cells (Caco-2)

被引:27
|
作者
Milovic, V
Stein, J
Odera, G
Gilani, S
Murphy, GM
机构
[1] UMDS, Guys Hosp, Div Med, Gastroenterol Unit, London SE1 7EH, England
[2] UMDS, Kings Hosp, Div Med, Gastroenterol Unit, London SE1 7EH, England
[3] UMDS, St Thomas Hosp, Div Med, Gastroenterol Unit, London SE1 7EH, England
[4] Univ Frankfurt, Dept Med 2, D-60590 Frankfurt, Germany
关键词
deoxycholic acid; polyamines; colon cancer; Caco-2; cells; cell culture;
D O I
10.1016/S0304-3835(00)00400-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Deoxycholic acid (DCA) has long been implicated as tumour-promoting agent in the colon. Polyamines are necessary for cell proliferation, they are accumulated in high amounts in colon cancer cells, and their concentrations in the colonic lumen can reach millimolar levels. The aim of this study was to investigate the effects of physiological DCA concentrations on proliferation and polyamine content in human colon cancer cells (Caco-2) in culture. Over an initial 48 h in culture, DCA stimulated Caco-2 cell proliferation rate three-fold, reaching a maximum with 20 muM DCA. DCA-induced increases in ornithine decarboxylase (ODC) activity corresponded to peak proliferation rates, occurring only during the initial 48 h of cell proliferation. Treatment with low-dose DCA resulted in a two-fold increase in putrescine uptake, first noted after 2 days in culture, but persisting until the cells became confluent (day 5). Both basal and DCA-stimulated putrescine uptake in Caco-2 cells were saturable. Kinetic analysis of the uptake data showed that DCA-stimulated putrescine uptake was due to an increase in the capacity of the putative putrescine transporter, without changes in its affinity, therefore implying an increased number of putrescine transporters in the cell membrane, without change in their structure. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:195 / 200
页数:6
相关论文
共 50 条
  • [1] Deoxycholic acid (DCA), polyamines and colon cancer: Low-dose DCA stimulates cell proliferation and putrescine uptake in cultured Caco-2 cells
    Milovic, V
    Murphy, GM
    Dowling, RH
    GUT, 1997, 41 : A251 - A251
  • [2] Deoxycholic acid stimulates migration in colon cancer cells
    Milovic, V
    Teller, IC
    Murphy, GM
    Caspary, WF
    Stein, J
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (08) : 945 - 949
  • [3] EGF STIMULATES POLYAMINE UPTAKE IN CACO-2 CELLS
    MILOVIC, V
    DEUBNER, C
    ZEUZEM, S
    PIIPER, A
    CASPARY, WF
    STEIN, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 206 (03) : 962 - 968
  • [4] EGF STIMULATES POLYAMINE UPTAKE IN CACO-2 CELLS
    MILOVIC, V
    DEUBNER, C
    ZEUZEM, S
    PIIPER, A
    CASPARY, WF
    STEIN, J
    GASTROENTEROLOGY, 1995, 108 (04) : A307 - A307
  • [5] Deoxycholic acid stimulates migration in colon cancer cells.
    Milovic, V
    Murphy, GA
    Dowling, RH
    Caspary, WF
    Stein, J
    GASTROENTEROLOGY, 1998, 114 (04) : A643 - A643
  • [6] Conjugated linoleic acid (CLA) stimulates oleamide production in human colon cancer Caco-2 cells.
    Kim, EJ
    Jun, JG
    Kim, SM
    Park, HS
    Ha, YL
    Park, JHY
    FASEB JOURNAL, 2002, 16 (04): : A370 - A370
  • [7] Putrescine transport in differentiated Caco-2 cells
    Barlier, AM
    Benamouzig, R
    Tome, D
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1996, 20 (02): : 178 - 184
  • [8] Curcumin decreases acid sphingomyelinase activity in colon cancer caco-2 cells
    Cheng, Yajun
    Kozubek, Agnieszka
    Ohlsson, Lena
    Sternby, Berit
    Duan, Rui-Dong
    PLANTA MEDICA, 2007, 73 (08) : 725 - 730
  • [9] Hypertonicity stimulates taurine uptake and transporter gene expression in Caco-2 cells
    Satsu, H
    Miyamoto, Y
    Shimizu, M
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1419 (01): : 89 - 96
  • [10] Enhancing effect of chemically conjugated deoxycholic acid on permeability of calcitonin in caco-2 cells
    Kim, S
    Lee, H
    Lee, S
    Kim, SK
    Lee, YK
    Chung, BH
    Moon, HT
    Byun, Y
    DRUG DEVELOPMENT RESEARCH, 2005, 64 (02) : 129 - 135